Tirzepatide Outperforms GLP-1 Drugs on Blood Sugar and Weight, Review Finds
A comparative narrative review finds tirzepatide delivers the largest HbA1c and weight reductions among incretin therapies, while semaglutide leads on ...
A comparative narrative review finds tirzepatide delivers the largest HbA1c and weight reductions among incretin therapies, while semaglutide leads on ...
Exit interviews with 74 long-term participants in the SURPASS-CVOT trial reveal that tirzepatide and dulaglutide produced perceived benefits in glycemic ...
A Bayesian re-analysis of six clinical trials estimates that people who stop semaglutide or tirzepatide regain roughly one kilogram per ...
The ongoing T-BEAT observational study is evaluating real-world glycemic and weight outcomes of tirzepatide versus oral semaglutide in Japanese adults ...
© 2025 Scienmag - Science Magazine
© 2025 Scienmag - Science Magazine